Since these cytokines play criticalroles in the differentiation of T helper (Th) 1 and Th17 cells and are likelyto contribute to the development of multiple sclerosis, this observationfurther support the potential role of PPAR-γ agonists in MS treatment [5, 64]. Here, PPARG is linked to myeloid sarcoma.